PHILADELPHIA--(BUSINESS WIRE)--Feb. 16, 2006--Hemispherx Biopharma, Inc. (AMEX: HEB): Tests Indicate Potential of Ampligen(R) As Vaccine Adjuvant, Boosts Existing Drugs Tamiflu(R), Relenza(R) Up To 100 Times; Alferon(R) LDO Found to Stimulate Production of Interferon, Offering Natural Defense Against Virus. Consortium of Researchers to Present Findings at Today’s ASM Biodefense Research Meeting in Washington, D.C.
